Advertisement
Tapping new dimensions: the promise of 3-D printing

Tapping new dimensions: the promise of 3-D printing

By Adam Rubenfire  |  May 21, 2016

Physicians have increasingly looked to 3-D printing for unique implants and surgical models, and some manufacturers are now using the method to mass produce medical devices and even drugs that are more precise, customizable and biocompatible than conventionally produced products.

Providers, environmental groups launch 'green' purchasing co-op

By Adam Rubenfire  |  May 17, 2016

Four major health systems have joined forces with two environmental organizations to launch a purchasing cooperative focused on “green” products that could compete with traditional group purchasing organizations.

Logistics: The next target in the war on device costs

Logistics: The next target in the war on device costs

By Adam Rubenfire  |  May 07, 2016

Hospitals—having spent the better part of the past decade working with their surgeons to narrow the variety of cardiovascular, orthopedic and other implants used in their operating rooms—are now looking for new ways to cut expenses related to these high-cost items.

AmerisourceBergen sees a rough road ahead

By Adam Rubenfire  |  May 05, 2016

Executives at AmerisourceBergen Corp. are concerned about the company's future, even though revenue growth was moderately positive this quarter.

Cardinal Health's drug sales boost overall revenue in Q3

By Michael Sandler  |  April 28, 2016

Cardinal Health reported a bump in revenue in its third quarter, driven by gains in the company's pharmaceutical segment. The Dublin, Ohio-based drug and medical products distributor reported $386 million in earnings during the last quarter, up 6% from last year.

Kaiser Permanente drops $525 million contract with Owens & Minor

By Adam Rubenfire  |  April 20, 2016

Kaiser Permanente has dropped its $525 million contract with Owens & Minor for medical-surgical supply distribution, marking the second time that the supplier has reported a major contract loss in less than a year.

FDA issues guidance on compounding drugs

By Adam Rubenfire  |  April 16, 2016

The FDA issued draft guidance last week that clarifies the amount of drugs that providers can compound without a prescription, sets requirements for health system compounding pharmacies and clarifies how large-scale compounding sites known as “outsourcing facilities” may be set up.

FDA clarifies compounding rules

FDA clarifies compounding rules

By Adam Rubenfire  |  April 15, 2016

The proposed rules clarify the amount of drugs that providers can compound without a prescription, set requirements for health system compounding pharmacies and clarify how large-scale compounding sites known as “outsourcing facilities” may be set up.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print